Levetiracetam NDC 72572-360

NDC codes

FDA NDC Directory

Product NDC (as listed)72572-360Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72572-0360Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72572-360-25	72572036025	25 VIAL in 1 CARTON (72572-360-25) / 5 mL in 1 VIAL (72572-360-01)Marketed from Dec 1, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levetiracetam
Generic name (nonproprietary): levetiracetam
Active ingredients: Levetiracetam — 100 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Civica, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090981
Marketing start: Dec 1, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 72572-360_2688af36-2f4b-499d-95a4-380f2e0d9787SPL ID 2688af36-2f4b-499d-95a4-380f2e0d9787SPL set ID 1591c690-f4ed-44b7-a9d0-bff1fbb4bfefRxCUI 647121UNII 44YRR34555

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472572036025 followed by a unit qualifier and the quantity

Package 72572-0360-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2025.

Indications (excerpt from the label)

Levetiracetam Injection is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) • Levetiracetam Injection is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy ( 1.2 ) Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy ( 1.3 ) • Levetiracetam Injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible ( 1.4 ) 1.1 Partial-Onset Seizures Levetiracetam Injection is indicated for the treatment of partial-onset seizures in patients 1 …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090981

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090981
Product	Strength	Form · route	Labeler	Product NDC
Levetiracetam	Levetiracetam 100 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9673
Levetiracetam	Levetiracetam 100 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9574